Since WCLC 2022, JTO, led by Dr. Alex A. Adjei, has continued to increase its impact factor, and JTO CRR has welcomed a new Editor-in-Chief, Dr. Emily Stone.
In an exclusive interview, Princess Dina talks with ILCN about her passion for improving equitable access to cancer care, tobacco control, prevention, and more.
Dr. Narjust Florez, who helped bring the session to fruition, will join other successful women in lung cancer as well as Her Royal Highness Princess Dina Mired of Jordan to discuss experiences, concerns, and solutions.
On Sunday eight investigators—including Dr. Anne-Marie Baird and the Go2 Foundation’s Brittney Nichols, MPH—will present research on global challenges in lung cancer care during the “Barriers and Benefits” mini oral abstract session.
In an interview with ILCN, Dr. Paul Van Schil discusses his goals of further strengthening the international character of the association and encouraging more scientific contribution, particularly from smaller specialties.
Monday afternoon, Drs. Anne Tsao and Maria Ftanou will offer institutional- and individual-level strategies to help healthcare providers take better care of themselves so they can continue to care for patients.
Sunday morning, hear nine state-of-the-art lectures spanning multiple specialties when the 2023 award winners take the stage during Plenary 2.
Drs. Myung-Ju Ahn, William K. Evans, Fernando Lopez-Rios, and Suresh Ramalingam were honored Saturday for their pioneering work in thoracic oncology.
As #WCLC23 gets under way, IASLC CEO Dr. Karen Kelly discusses some of the meeting’s highlights during an interview with ILCN.
Presentations from Her Royal Highness Princess Dina Mired and renowned researcher Dr. Gary Rodin will bring attention to imbalances in cancer care.